Altria (MO) Q2 2026 Earnings Call Transcript
Thursday, July 30, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Mac Livingston Chief Executive Officer - Salvatore Mancuso Chief Financial Officer - Heather Newman TAKEAWAYS Adjusted Diluted EPS -- $1.48 for the second quarter, representing a 2.8% increase, and $2.80 for the first half, up 4.9%. Full-Year Guidance -- Narrowed to a range of $5.61 to $5.72, representing a growth rate of 3.5% to 5.5% from the 2025 base of $5.42.
How this was made
The 30-second read
Why it matters
Key decision inputs are the updated full-year EPS guidance range, smokeable OCI margin stability, cigarette volume trends adjusted for trade inventory, and smoke-free progress (on! PLUS store expansion and share) alongside oral OCI weakness and NJOY ACE PMTA re-entry plans.
Market read
The transcript updates traders on where earnings growth is expected to land for 2026 and how smoke-free expansion is progressing versus ongoing cigarette volume pressure.
What to watch
Traders may be underweighting the timing of tax and duty refunds and the operational drag from trade inventory movements, which can distort quarter-to-quarter comparisons.
Background
Altria’s 2026 Q2 earnings call covers adjusted EPS, full-year guidance, smokeable and oral segment KPIs, capital returns, and regulatory updates for nicotine pouch products.
Ticker impact
Altria guided full-year adjusted diluted EPS to $5.61 to $5.72 and reported Q2 adjusted diluted EPS of $1.48, plus smokeable OCI $3.0B.
Likely modest volatility around guidance range and segment mix, with traders focusing on whether smoke-free growth offsets cigarette volume declines.
This is a primary earnings call transcript with specific EPS guidance and operating KPIs, but it is not a surprise regulatory ruling or deal that would typically create a large repricing by itself.
Market effects
Reinforces the US tobacco read-through that pricing discipline and smoke-free portfolio expansion are offsetting volume pressure, with illicit e-vapor enforcement moderating category growth.
Limited direct regional impact; largely US consumer and FDA/PMTA-driven dynamics.
Low, as the disclosed drivers are primarily US regulatory and domestic volume/mix metrics.
Counterpoint
The guidance range is narrowed but still implies only mid-single-digit growth from a 2025 base, while cigarette volume continues to decline and oral OCI fell 8%.
Key entities
- companyAltria Group, Inc.
US tobacco company reporting Q2 2026 results, narrowed full-year EPS guidance, and segment operating metrics on smokeable and smoke-free products.
- executiveSalvatore Mancuso
CEO who discussed consumer pressure, cigarette dynamics, and moderating illicit e-vapor growth.
- executiveHeather Newman
CFO who explained timing factors behind tax and duty refunds and provided financial framing for the quarter.
